EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl‐Hydrocarbon Receptors Pathway in Non‐Alcoholic Steatohepatitis Mice

Paulraj Kanmani, Julio Villena, Soo-Kyoung Lim, Eun-Ji Song, Young-Do Nam, Hojun Kim iD

Molecular Nutrition & Food Research · 2024

DOI: 10.1002/mnfr.202400227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Paulraj Kanmani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang, 10326, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Receptors, Aryl Hydrocarbon. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Food Research Institute, Korea Health Industry Development Institute, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scope Nonalcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease worldwide that can progress to liver fibrosis (LF). Probiotics have beneficial roles in reducing intestinal inflammation and gut‐associated diseases, but their effects and mechanisms beyond the gut in attenuating the progression of LF are remained unclear. Methods and results In a mouse model of NASH/LF induced by a methionine‐choline deficient (MCD) diet, immunobiotics are administered to investigate their therapeutic effects. Results show that the MCD diet leads to liver inflammation, steatosis, and fibrosis, which are alleviated by immunobiotics. Immunobiotics reduces serum endotoxin and inflammatory markers while increasing regulatory cytokines and liver weight. They also suppress Th17 cells, known for producing inflammatory cytokines. Furthermore, immunobiotics mitigate collagen deposition and fibrogenic signaling in the liver, while restoring gut‐barrier integrity and microbiota composition. Additionally, immunobiotics enhance the activation of the aryl hydrocarbon receptor (AhR) pathway in both colonic and liver tissues. Conclusions Overall, these results demonstrate a novel insight into the mechanisms through which immunobiotic administration improves the gut health which in turn increases the AhR pathway and inhibits HSCs activation and fibrosis progression beyond the gut in the liver tissue of NASH/LF mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLiver CirrhosisNon-alcoholic Fatty Liver DiseaseReceptors, Aryl HydrocarbonAnimalsMaleMiceCytokinesDisease Models, AnimalLiverMethionineMice, Inbred C57BLProbioticsSignal TransductionTh17 Cells

Stichwörter der Autor:innen

gut microbiotaimmunobioticsimmunoregulationliver fibrosisnon‐alcoholic steatohepatitis

Substanzen

CytokinesMethionineReceptors, Aryl Hydrocarbon

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang, 10326, Republic of Korea.
  • Department of Anesthesiology, University of Illinois, Chicago, IL, 60612, USA.
  • Laboratory of Immunobiotechnology, Reference Centre for Lactobacilli (CERELA-CONICET), Tucuman, 4000, Argentina.
  • Research Group of Gut Microbiome, Korea Food Research Institute, Wanju-gun 245, Wanju-gun, 55365, Republic of Korea.
  • Department of Food Biotechnology, Korea University of Science and Technology, Wanju, 55365, Republic of Korea.

ORCID-Profile: Hojun Kim

Förderung

  • Korea Food Research Institute
  • Korea Health Industry Development Institute
  • National Research Foundation of Korea

Zitieren

APA

Kanmani, P., Villena, J., Lim, S. K., Song, E. J., Nam, Y. D., & Kim, H. (2024). Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl‐Hydrocarbon Receptors Pathway in Non‐Alcoholic Steatohepatitis Mice. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202400227

Vancouver

Kanmani P, Villena J, Lim SK, Song EJ, Nam YD, Kim H. Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl‐Hydrocarbon Receptors Pathway in Non‐Alcoholic Steatohepatitis Mice. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202400227

BibTeX
@article{Kanmani2024,
  author = {Kanmani, Paulraj and Villena, Julio and Lim, Soo-Kyoung and Song, Eun-Ji and Nam, Young-Do and Kim, Hojun},
  title = {Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl‐Hydrocarbon Receptors Pathway in Non‐Alcoholic Steatohepatitis Mice},
  journal = {Molecular Nutrition & Food Research},
  year = {2024},
  doi = {10.1002/mnfr.202400227}
}
Kostenlos starten →